Screening for Keratoconus in Children with Down Syndrome in Tashkent
On August 12, 2023, at Humo Arena, Tashkent, 63 Down syndrome children were screened for keratoconus under Nikki Hafezi’s leadership. Discover the importance of early detection.
On August 12, 2023, at Humo Arena, Tashkent, 63 Down syndrome children were screened for keratoconus under Nikki Hafezi’s leadership. Discover the importance of early detection.
Ophthalmologie Nachrichten recently featured an article from the ELZA Institute, highlighting advancements in corneal cross-linking (CXL). This new approach allows the procedure to be conducted at the slit lamp, significantly reducing costs and extending access to advanced eye care in underserved regions. The innovative method is especially effective for treating keratoconus and infectious keratitis. By optimizing UV exposure times, ELZA’s researchers have made CXL more efficient and accessible, democratizing high-quality ophthalmic treatments globally.
Nikki Hafezi, a partner of MESCA Foundation, is leading healthcare transformation in Uzbekistan. MESCA, founded in 2021 by Bakhtiyor Fazylov, focuses on medical education, training, and research. It aims to enhance ophthalmological care, particularly addressing keratoconus, a significant cause of preventable blindness in children. MESCA’s initiatives include training local healthcare professionals and collaborating with institutions like the Andijan State Medical Institute to improve medical practice and education.
Nikki Hafezi, a partner of MESCA Foundation, is leading healthcare transformation in Uzbekistan. MESCA, founded in 2021 by Bakhtiyor Fazylov, focuses on medical education, training, and research. It aims to enhance ophthalmological care, particularly addressing keratoconus, a significant cause of preventable blindness in children. MESCA’s initiatives include training local healthcare professionals and collaborating with institutions like the Andijan State Medical Institute to improve medical practice and education.
By offering a non-surgical option that improves vision and comfort, mini scleral contact lenses can enhance the quality of life for patients with otherwise challenging visual impairments. Future research could further explore long-term outcomes and compare mini scleral contact lenses with other rehabilitative options to solidify their role in ophthalmic care.
CXL at the slit lamp uses the same UV irradiation settings and riboflavin concentration as in the operating room, achieving identical results. Patients generally tolerate the procedure well, especially with adjustments for comfort and higher UV intensities that shorten treatment time.
ELZA’s medical director, Prof. Dr. Farhad Hafezi MD, PhD, FARVO, was invited to give two lectures this afternoon at the 18th Annual Meeting of the Moroccan Society of Refractive Surgery and Implantology (SAMIR) in Rabat, Morocco.
ELZA’s research has led to the development of portable corneal cross-linking devices which democratize access to essential eye care, transforming treatment for keratoconus and infectious keratitis in low-to-middle-income countries.
When considering eyelid surgery, choosing an oculoplastic surgeon ensures specialized care for both cosmetic and functional outcomes. With extensive training in ophthalmology and plastic surgery, oculoplastic surgeons offer unparalleled expertise in the periorbital region. Discover why an oculoplastic surgeon should be your top choice for safe, precise, and aesthetically pleasing results.
Nikki Hafezi’s recent visit to Tashkent’s School No.178, the first public school in Uzbekistan to join the K-MAP study, emphasized the importance of keratoconus prevalence research and the inspiring potential of youth. Her engagement highlights the vital link between education and health initiatives.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.